Why the study?
Does the combination of dihydroergotamine and heparin prevent postoperative deep-vein thrombosis better than either agent alone in patients undergoing major abdominal surgery or hip replacement arthroplasty?
Does the combination of dihydroergotamine and heparin prevent postoperative deep-vein thrombosis better than either agent alone in patients undergoing major abdominal surgery or hip replacement arthroplasty?
The combination of dihydroergotamine and heparin is more effective than monotherapy for DVT prophylaxis after major abdominal or hip surgery.
Answers are grounded in this paper and cite their sources.
Supports combined dihydroergotamine-heparin prophylaxis after major abdominal or hip surgery; confirms additive efficacy over monotherapy in this RCT.
Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to investigate the efficacy of dihydroergotamine mesylate, heparin calcium, or a combination of dihydroergotamine with heparin in preventing postoperative deep-vein thrombosis (DVT). The diagnosis of DVT was established by an uptake test using fibrinogen labeled with iodine 125; in patients undergoing hip replacement, phlebography was also employed to confirm or refute the presence of isotopic thrombi. The data indicate that the combination of dihydroergotamine and heparin is more effective than heparin or dihydroergotamine alone in preventing DVT. (JAMA241:39-42, 1979)
No takes yet. Share an insight, caveat, or question.
Vijay V. Kakkar (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: